Clinical Trials Browser

Phase 1 × Neoplasm Metastasis × pemigatinib × Clear all

NCT06302621 2026-05-15

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

Phase 1 Recruiting

Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma